Notice of Hearing: Reconsideration of Disapproval of Washington State Plan Amendment (SPA) 08-019, 29703-29704 [E9-14776]

Download as PDF Federal Register / Vol. 74, No. 119 / Tuesday, June 23, 2009 / Notices provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; RFA AT09–002 Translational Tools for Clinical Studies of CAM Interventions. Date: July 15, 2009. Time: 12 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Ray Bramhall, PhD, Scientific Review Officer, National Center for Complementary and Alternative Medicine, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, bramhallr@mail.nih.gov. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; Botanical Centers. Date: August 2–3, 2009. Time: 5 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard Marriott Washingtonian Center, 204 Boardwalk Place, Gaithersburg, MD 20814. Contact Person: Martina Schmidt, PhD, Scientific Review Officer, Office of Scientific Review, National Center for Complementary & Alternative Medicine, NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, 301–594–3456, schmidma@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training in Complementary and Alternative Medicine, National Institutes of Health, HHS) 29703 DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): American Recovery and Reinvestment Act (ARRA)-Section 317 Immunization Program: Strengthening the Evidence Base Measuring Effectiveness of Two Dose of Varicella Vaccine, Funding Opportunity Announcement (FOA) IP04–11601ARRA09, Initial Review Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Translating Research To Protect Health Through Health Promotion, Prevention, and Preparedness, Panel D, Funding Opportunity Announcement (FOA) CD09–001, Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 12 p.m.–2 p.m., July 28, 2009 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘ARRA-Section 317 Immunization Program: Strengthening the Evidence Base Measuring Effectiveness of Two Dose of Varicella Vaccine, FOA IP04– 11601ARRA09.’’ For More Information Contact: Wendy Carr, PhD, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, GA 30333, Telephone: (404) 498–2276. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 17, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–14701 Filed 6–22–09; 8:45 am] Dated: June 12, 2009. Elaine L. Baker, Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. E9–14664 Filed 6–22–09; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4163–18–P In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 9 a.m.–5 p.m., July 21, 2009 (Closed). 9 a.m.–1 p.m., July 22, 2009 (Closed). Place: W Hotel, Midtown, 188 14th Street, NE., Atlanta, Georgia 30361, Telephone: (404) 892–6000. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Translating Research to Protect Health through Health Promotion, Prevention, and Preparedness, Panel D, FOA CD09–001, initial review.’’ For More Information Contact: Christine J. Morrison, PhD, Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone (404) 639–3098. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 15, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–14659 Filed 6–22–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services Notice of Hearing: Reconsideration of Disapproval of Washington State Plan Amendment (SPA) 08–019 AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice of Hearing. VerDate Nov<24>2008 16:15 Jun 22, 2009 Jkt 217001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 E:\FR\FM\23JNN1.SGM 23JNN1 29704 Federal Register / Vol. 74, No. 119 / Tuesday, June 23, 2009 / Notices SUMMARY: This notice announces an administrative hearing to be held on August 4, 2009, at the CMS Seattle Regional Office, 2201 Sixth Avenue, MS/RX–43, Seattle, Washington 98121, to reconsider CMS’ decision to disapprove Washington SPA 08–019. CLOSING DATE: Requests to participate in the hearing as a party must be received by the presiding officer by 15 days after publication. FOR FURTHER INFORMATION CONTACT: Benjamin Cohen, Presiding Officer, CMS, 2520 Lord Baltimore Drive, Suite L, Baltimore, Maryland 21244, Telephone: (410) 786–3169. SUPPLEMENTARY INFORMATION: This notice announces an administrative hearing to reconsider CMS’ decision to disapprove Washington SPA 08–019 which was received by CMS on September 23, 2008, and disapproved on March 6, 2009. The SPA proposed to increase dispensing fees for pharmacies from $4.20 to $4.24 for high-volume pharmacies, $4.51 to $4.56 for midvolume pharmacies, $5.20 to $5.25 for low-volume pharmacies, and $5.20 to $5.25 for unit dose systems. As submitted, SPA 08–019 has raised concerns regarding compliance with section 1902(a)(30) of the Social Security Act (the Act) and implementing regulatory requirements. Section 1902(a)(30)(A) of the Act requires that States have methods and procedures in place to assure that payments are consistent with efficiency, economy, and quality of care. Under that authority, the Secretary has issued regulations prescribing State rate-setting procedures and requirements. Longstanding requirements (presently codified at 42 CFR 447.512 and 447.514, and previously codified at 42 CFR 447.331 and 447.332) provide that the State is responsible for demonstrating that the dispensing fees are reasonable. The State has not provided that demonstration. In addition, Federal regulations at 42 CFR 447.205 require that a State provide public notice of any significant proposed change in its methods and standards for setting payment rates for services. In support of this amendment, the State believes that issuing a memorandum to providers online meets the public requirements. We believe that this does not meet the Federal standard. We believe public notice promotes transparency and openness in this process and allows the public to be fully aware of the State’s actions. Based on the above, and after consultation with the Secretary of the Department of Health and Human VerDate Nov<24>2008 16:15 Jun 22, 2009 Jkt 217001 Services as required under Federal regulations at 42 CFR 430.15(c)(2), Washington SPA 08–019 was disapproved. The following issues will be considered at the hearing: • Whether Washington provided adequate public notice for setting payment rates for services as required at 42 CFR 447.205. • Whether Washington met the longstanding requirement (presently codified at 42 CFR 447.512 and 447.514, and previously codified in 42 CFR 447.331 and 447.332) that the State is responsible for demonstrating that the proposed increased dispensing fees are reasonable. Section 1116 of the Act and Federal regulations at 42 CFR Part 430, establish Department procedures that provide an administrative hearing for reconsideration of a disapproval of a State plan or plan amendment. CMS is required to publish a copy of the notice to a State Medicaid agency that informs the agency of the time and place of the hearing, and the issues to be considered. If CMS subsequently notifies the agency of additional issues that will be considered at the hearing, we will also publish that notice. Any individual or group that wants to participate in the hearing as a party must petition the presiding officer within 15 days after publication of this notice, in accordance with the requirements contained at 42 CFR 430.76(b)(2). Any interested person or organization that wants to participate as amicus curiae must petition the presiding officer before the hearing begins in accordance with the requirements contained at 42 CFR 430.76(c). If the hearing is later rescheduled, the presiding officer will notify all participants. The notice to the State of Washington announcing an administrative hearing to reconsider the disapproval of its SPA reads as follows: Ms. Susan Dreyfus Secretary Department of Social and Health Services P.O. Box 45010 Olympia, WA 98504–5010 Dear Ms. Dreyfus: I am responding to your request for reconsideration of the decision to disapprove the Washington State plan amendment (SPA) 08–019, which was received by the Centers for Medicare & Medicaid Services on September 23, 2008, and disapproved on March 6, 2009. The SPA proposed to increase dispensing fees for pharmacies from $4.20 to $4.24 for high-volume PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 pharmacies, $4.51 to $4.56 for midvolume pharmacies, $5.20 to $5.25 for low-volume pharmacies, and $5.20 to $5.25 for unit dose systems. The following issues will be considered at the hearing: • Whether Washington provided adequate public notice for setting payment rates for services as required at 42 CFR 447.205. • Whether Washington met the longstanding requirement (presently codified at 42 CFR 447.512 and 447.514, and previously codified in 42 CFR 447.331 and 447.332) that the State is responsible for demonstrating that the proposed increased dispensing fees are reasonable. I am scheduling a hearing on your request for reconsideration to be held on August 4, 2009, at the Centers for Medicare & Medicaid Services’ Seattle Regional Office, 2201 Sixth Avenue, MS/RX–43, Seattle, Washington 98121, in order to reconsider the decision to disapprove SPA 08–019. If this date is not acceptable, we would be glad to set another date that is mutually agreeable to the parties. The hearing will be governed by the procedures prescribed by Federal regulations at 42 CFR Part 430. I am designating Mr. Benjamin Cohen as the presiding officer. If these arrangements present any problems, please contact the presiding officer at (410) 786–3169. In order to facilitate any communication which may be necessary among the parties to the hearing, please notify the presiding officer to indicate acceptability of the hearing date that has been scheduled and provide names of the individuals who will represent the State at the hearing. Sincerely, Charlene Frizzera Acting Administrator Section 1116 of the Social Security Act (42 U.S.C. section 1316; 42 CFR section 430.18) (Catalog of Federal Domestic Assistance program No. 13.714, Medicaid Assistance Program.) Dated: June 16, 2009. Charlene Frizzera, Acting Administrator, Centers for Medicare & Medicaid Services. [FR Doc. E9–14776 Filed 6–22–09; 8:45 am] BILLING CODE P E:\FR\FM\23JNN1.SGM 23JNN1

Agencies

[Federal Register Volume 74, Number 119 (Tuesday, June 23, 2009)]
[Notices]
[Pages 29703-29704]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-14776]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services


Notice of Hearing: Reconsideration of Disapproval of Washington 
State Plan Amendment (SPA) 08-019

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Notice of Hearing.

-----------------------------------------------------------------------

[[Page 29704]]

SUMMARY: This notice announces an administrative hearing to be held on 
August 4, 2009, at the CMS Seattle Regional Office, 2201 Sixth Avenue, 
MS/RX-43, Seattle, Washington 98121, to reconsider CMS' decision to 
disapprove Washington SPA 08-019.

Closing Date: Requests to participate in the hearing as a party must be 
received by the presiding officer by 15 days after publication.

FOR FURTHER INFORMATION CONTACT: Benjamin Cohen, Presiding Officer, 
CMS, 2520 Lord Baltimore Drive, Suite L, Baltimore, Maryland 21244, 
Telephone: (410) 786-3169.

SUPPLEMENTARY INFORMATION: This notice announces an administrative 
hearing to reconsider CMS' decision to disapprove Washington SPA 08-019 
which was received by CMS on September 23, 2008, and disapproved on 
March 6, 2009. The SPA proposed to increase dispensing fees for 
pharmacies from $4.20 to $4.24 for high-volume pharmacies, $4.51 to 
$4.56 for mid-volume pharmacies, $5.20 to $5.25 for low-volume 
pharmacies, and $5.20 to $5.25 for unit dose systems.
    As submitted, SPA 08-019 has raised concerns regarding compliance 
with section 1902(a)(30) of the Social Security Act (the Act) and 
implementing regulatory requirements. Section 1902(a)(30)(A) of the Act 
requires that States have methods and procedures in place to assure 
that payments are consistent with efficiency, economy, and quality of 
care.
    Under that authority, the Secretary has issued regulations 
prescribing State rate-setting procedures and requirements. 
Longstanding requirements (presently codified at 42 CFR 447.512 and 
447.514, and previously codified at 42 CFR 447.331 and 447.332) provide 
that the State is responsible for demonstrating that the dispensing 
fees are reasonable. The State has not provided that demonstration. In 
addition, Federal regulations at 42 CFR 447.205 require that a State 
provide public notice of any significant proposed change in its methods 
and standards for setting payment rates for services. In support of 
this amendment, the State believes that issuing a memorandum to 
providers online meets the public requirements. We believe that this 
does not meet the Federal standard. We believe public notice promotes 
transparency and openness in this process and allows the public to be 
fully aware of the State's actions.
    Based on the above, and after consultation with the Secretary of 
the Department of Health and Human Services as required under Federal 
regulations at 42 CFR 430.15(c)(2), Washington SPA 08-019 was 
disapproved.
    The following issues will be considered at the hearing:
     Whether Washington provided adequate public notice for 
setting payment rates for services as required at 42 CFR 447.205.
     Whether Washington met the longstanding requirement 
(presently codified at 42 CFR 447.512 and 447.514, and previously 
codified in 42 CFR 447.331 and 447.332) that the State is responsible 
for demonstrating that the proposed increased dispensing fees are 
reasonable.
    Section 1116 of the Act and Federal regulations at 42 CFR Part 430, 
establish Department procedures that provide an administrative hearing 
for reconsideration of a disapproval of a State plan or plan amendment. 
CMS is required to publish a copy of the notice to a State Medicaid 
agency that informs the agency of the time and place of the hearing, 
and the issues to be considered. If CMS subsequently notifies the 
agency of additional issues that will be considered at the hearing, we 
will also publish that notice.
    Any individual or group that wants to participate in the hearing as 
a party must petition the presiding officer within 15 days after 
publication of this notice, in accordance with the requirements 
contained at 42 CFR 430.76(b)(2). Any interested person or organization 
that wants to participate as amicus curiae must petition the presiding 
officer before the hearing begins in accordance with the requirements 
contained at 42 CFR 430.76(c). If the hearing is later rescheduled, the 
presiding officer will notify all participants.
    The notice to the State of Washington announcing an administrative 
hearing to reconsider the disapproval of its SPA reads as follows:
Ms. Susan Dreyfus
Secretary
Department of Social and Health Services
P.O. Box 45010
Olympia, WA 98504-5010

Dear Ms. Dreyfus:
    I am responding to your request for reconsideration of the decision 
to disapprove the Washington State plan amendment (SPA) 08-019, which 
was received by the Centers for Medicare & Medicaid Services on 
September 23, 2008, and disapproved on March 6, 2009. The SPA proposed 
to increase dispensing fees for pharmacies from $4.20 to $4.24 for 
high-volume pharmacies, $4.51 to $4.56 for mid-volume pharmacies, $5.20 
to $5.25 for low-volume pharmacies, and $5.20 to $5.25 for unit dose 
systems.
    The following issues will be considered at the hearing:
     Whether Washington provided adequate public notice for 
setting payment rates for services as required at 42 CFR 447.205.
     Whether Washington met the longstanding requirement 
(presently codified at 42 CFR 447.512 and 447.514, and previously 
codified in 42 CFR 447.331 and 447.332) that the State is responsible 
for demonstrating that the proposed increased dispensing fees are 
reasonable.
    I am scheduling a hearing on your request for reconsideration to be 
held on August 4, 2009, at the Centers for Medicare & Medicaid 
Services' Seattle Regional Office, 2201 Sixth Avenue, MS/RX-43, 
Seattle, Washington 98121, in order to reconsider the decision to 
disapprove SPA 08-019. If this date is not acceptable, we would be glad 
to set another date that is mutually agreeable to the parties. The 
hearing will be governed by the procedures prescribed by Federal 
regulations at 42 CFR Part 430.
    I am designating Mr. Benjamin Cohen as the presiding officer. If 
these arrangements present any problems, please contact the presiding 
officer at (410) 786-3169. In order to facilitate any communication 
which may be necessary among the parties to the hearing, please notify 
the presiding officer to indicate acceptability of the hearing date 
that has been scheduled and provide names of the individuals who will 
represent the State at the hearing.

    Sincerely,

    Charlene Frizzera

    Acting Administrator

Section 1116 of the Social Security Act (42 U.S.C. section 1316; 42 
CFR section 430.18)
(Catalog of Federal Domestic Assistance program No. 13.714, Medicaid 
Assistance Program.)

    Dated: June 16, 2009.
Charlene Frizzera,
Acting Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. E9-14776 Filed 6-22-09; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.